13F HOLDINGS REPORT
Pfizer Inc
Quarter ended Q1 2025 · Filed May 13, 2025 · Accession 0000078003-25-000118
Total Value
$500.8M
Positions
24
Other Managers
0
Confidential Omitted
No
Holdings (24)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | BIONTECH SE | BNTX | 3,658,361 | $333.1M | 66.51% |
| 2 | ALLOGENE THERAPEUTICS INC | ALLO | 22,032,040 | $32.2M | 6.42% |
| 3 | ORIC PHARMACEUTICALS INC | ORIC | 5,376,344 | $30.0M | 5.99% |
| 4 | ARVINAS INC | ARVN | 3,457,815 | $24.3M | 4.85% |
| 5 | TOURMALINE BIO INC | 89157D105 | 1,272,214 | $19.4M | 3.86% |
| 6 | WAVE LIFE SCIENCES LTD | WVE | 1,875,000 | $15.2M | 3.02% |
| 7 | BIOHAVEN LTD | BHVN | 505,645 | $12.2M | 2.43% |
| 8 | CARDIFF ONCOLOGY INC | CRDF | 2,411,575 | $7.6M | 1.51% |
| 9 | PYXIS ONCOLOGY INC | PYXS | 5,952,263 | $5.8M | 1.16% |
| 10 | CARIBOU BIOSCIENCES INC | CRBU | 4,690,431 | $4.3M | 0.86% |
| 11 | ZURA BIO LTD | ZURA | 2,970,022 | $3.8M | 0.76% |
| 12 | CELCUITY INC | CELC | 349,406 | $3.5M | 0.71% |
| 13 | ESSA PHARMA INC | 29668H708 | 1,675,000 | $2.6M | 0.53% |
| 14 | SPERO THERAPEUTICS INC | SPRO | 2,362,348 | $1.7M | 0.34% |
| 15 | ZENTALIS PHARMACEUTICALS INC | ZNTL | 953,834 | $1.5M | 0.30% |
| 16 | PYXIS ONCOLOGY INC | PYXS | 1,080,507 | $1.1M | 0.21% |
| 17 | AN2 THERAPEUTICS INC | ANTX | 715,295 | $972,801 | 0.19% |
| 18 | NEXTCURE INC | NXTC | 1,573,312 | $755,662 | 0.15% |
| 19 | Q32 BIO INC | QTTB | 277,777 | $458,332 | 0.09% |
| 20 | BOLT BIOTHERAPEUTICS INC | BOLT | 626,109 | $250,444 | 0.05% |
| 21 | NEXTCURE INC | NXTC | 318,451 | $152,952 | 0.03% |
| 22 | SENSEONICS HLDGS INC | SENS | 43,426 | $28,492 | 0.01% |
| 23 | GINKGO BIOWORKS HOLDINGS INC | DNABW | 2,681 | $15,282 | 0.00% |
| 24 | GINKGO BIOWORKS HOLDINGS INC | DNABW | 247 | $1,408 | 0.00% |